Esther Welkowsky
Direttore Tecnico/Scientifico/R&S presso ELICIO THERAPEUTICS, INC.
Posizioni attive di Esther Welkowsky
Società | Posizione | Inizio | Fine |
---|---|---|---|
ELICIO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/04/2020 | - |
Storia della carriera di Esther Welkowsky
Precedenti posizioni note di Esther Welkowsky
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALLOGENE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2018 | 01/02/2020 |
ATARA BIOTHERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Esther Welkowsky
University of California, Santa Barbara | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
ALLOGENE THERAPEUTICS, INC. | Health Technology |
ATARA BIOTHERAPEUTICS, INC. | Health Technology |
ELICIO THERAPEUTICS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Esther Welkowsky
- Esperienza